Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Gums

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Pharmacotherapy|October 2, 2009
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) studySteven M Smith, Shawn D Anderson, Sheron Wen, et al.
Journal of the American Heart Association|November 4, 2017
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) TrialsOyunbileg Magvanjav, Yan Gong, Caitrin W McDonough, et al.
Journal of Clinical Pharmacology|May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical StudiesMohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Journal of Hypertension|January 29, 2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diureticsCaitrin W McDonough, Sarah E Burbage, Julio D Duarte, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2019
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studiesMohamed H Solayman, Taimour Y Langaee, Yan Gong, et al.
Pharmacotherapy|September 10, 2014
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazideMariellen J Moore, Yan Gong, Wei Hou, et al.
Journal of the American Heart Association|November 12, 2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertensionVanessa Fontana, Caitrin W McDonough, Yan Gong, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approachFelipe A de Oliveira, Mohamed H Shahin, Yan Gong, et al.
Pharmacogenetics and Genomics|October 6, 2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazideSonal Singh, Zhiying Wang, Mohamed H Shahin, et al.
Journal of Translational Medicine|March 24, 2012
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazideJulio D Duarte, Issam Zineh, Ben Burkley, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Pharmacotherapy|October 2, 2009
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) studySteven M Smith, Shawn D Anderson, Sheron Wen, et al.
Journal of the American Heart Association|November 4, 2017
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) TrialsOyunbileg Magvanjav, Yan Gong, Caitrin W McDonough, et al.
Journal of Clinical Pharmacology|May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical StudiesMohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Journal of Hypertension|January 29, 2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diureticsCaitrin W McDonough, Sarah E Burbage, Julio D Duarte, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 13, 2019
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studiesMohamed H Solayman, Taimour Y Langaee, Yan Gong, et al.
Pharmacotherapy|September 10, 2014
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazideMariellen J Moore, Yan Gong, Wei Hou, et al.
Journal of the American Heart Association|November 12, 2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertensionVanessa Fontana, Caitrin W McDonough, Yan Gong, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approachFelipe A de Oliveira, Mohamed H Shahin, Yan Gong, et al.
Pharmacogenetics and Genomics|October 6, 2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazideSonal Singh, Zhiying Wang, Mohamed H Shahin, et al.
Journal of Translational Medicine|March 24, 2012
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazideJulio D Duarte, Issam Zineh, Ben Burkley, et al.
Pageof 10